- Illumina inc.: Guggenheim Securities maintains buy rating; target cut to $122 from $150, a 48% potential increase.
- Exact sciences corp.: Guggenheim Securities maintains buy rating; target cut to $60 from $73, a 33% potential increase.
- Danaher corp.: Guggenheim Securities maintains buy rating; target cut to $250 from $275, a 19% potential increase.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.